ES2057454T3 - Antibiotico l53-18a y procedimiento para su preparacion. - Google Patents

Antibiotico l53-18a y procedimiento para su preparacion.

Info

Publication number
ES2057454T3
ES2057454T3 ES90400032T ES90400032T ES2057454T3 ES 2057454 T3 ES2057454 T3 ES 2057454T3 ES 90400032 T ES90400032 T ES 90400032T ES 90400032 T ES90400032 T ES 90400032T ES 2057454 T3 ES2057454 T3 ES 2057454T3
Authority
ES
Spain
Prior art keywords
antibiotic
procedure
preparation
medium
sacaropolispora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90400032T
Other languages
English (en)
Inventor
Satoshi Yaginuma
Atsuki Morishita
Naoki Muto
Kenya Ishizawa
Misuo Hayashi
Tetsu Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2057454T3 publication Critical patent/ES2057454T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN NUEVO ANTIBIOTICO L53-18A Y UNA SAL FARMACEUTICAMENTE ACEPTABLE ES UTIL PARA EL TRATAMIENTO DE LAS INFECCIONES BACTERIANAS; SE OBTIENEN POR MEDIO DE CULTIVOS, POR EJEMPLO, LA SACAROPOLISPORA SP.L53-18 (FERM BP 2231) EN UNH MEDIUM Y SE RECOGE EL ANTIBIOTICO ACUMULADO EN DICHO MEDIUM.
ES90400032T 1989-01-20 1990-01-05 Antibiotico l53-18a y procedimiento para su preparacion. Expired - Lifetime ES2057454T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1009647A JP2787458B2 (ja) 1989-01-20 1989-01-20 抗生物質ｌ５３―１８ａおよびその製造法

Publications (1)

Publication Number Publication Date
ES2057454T3 true ES2057454T3 (es) 1994-10-16

Family

ID=11726011

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90400032T Expired - Lifetime ES2057454T3 (es) 1989-01-20 1990-01-05 Antibiotico l53-18a y procedimiento para su preparacion.

Country Status (6)

Country Link
US (1) US5081023A (es)
EP (1) EP0379395B1 (es)
JP (1) JP2787458B2 (es)
CA (1) CA2008147A1 (es)
DE (1) DE69010924T2 (es)
ES (1) ES2057454T3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171740A (en) * 1988-10-21 1992-12-15 Abbott Laboratories Coumamidine compounds
US6063561A (en) * 1991-01-17 2000-05-16 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
EP1171447A2 (en) 1999-04-16 2002-01-16 Ortho-McNeil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US8092559B2 (en) * 2004-05-12 2012-01-10 Luca Technologies, Inc. Generation of hydrogen from hydrocarbon bearing materials
US20100248322A1 (en) * 2006-04-05 2010-09-30 Luca Technologies, Inc. Chemical amendments for the stimulation of biogenic gas generation in deposits of carbonaceous material
US7696132B2 (en) * 2006-04-05 2010-04-13 Luca Technologies, Inc. Chemical amendments for the stimulation of biogenic gas generation in deposits of carbonaceous material
US7977282B2 (en) * 2006-04-05 2011-07-12 Luca Technologies, Inc. Chemical amendments for the stimulation of biogenic gas generation in deposits of carbonaceous material
US20100248321A1 (en) * 2009-03-27 2010-09-30 Luca Technologies, Inc. Surfactant amendments for the stimulation of biogenic gas generation in deposits of carbonaceous materials
CN110914425B (zh) 2017-06-06 2024-06-25 齐默尔根公司 用于改良刺糖多孢菌的高通量(htp)基因组工程改造平台

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125203A (en) * 1978-05-10 1982-06-08 Toyo Jozo Company, Ltd. Macrolide antibiotics from micromonospora
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
US4358584A (en) * 1979-05-23 1982-11-09 Eli Lilly And Company Antibiotics A6888C and A6888X
US4251511A (en) * 1979-10-02 1981-02-17 The Upjohn Company Antibiotic and fermentation process of preparing
US4293651A (en) * 1979-10-02 1981-10-06 The Upjohn Company Process for producing antibiotic using saccharopolyspora
US4351769A (en) * 1980-08-25 1982-09-28 The Upjohn Company Antibiotic composition of matter
CH656622A5 (de) * 1981-12-08 1986-07-15 Toyo Jozo Kk Aminoglycosid-antibiotika saccharocine und deren herstellung.
JPS61119193A (ja) * 1984-11-15 1986-06-06 Toyo Jozo Co Ltd 新規抗生物質ａｓｅ−９及びその製造法
US4935340A (en) * 1985-06-07 1990-06-19 Eli Lilly And Company Method of isolating antibiotic biosynthetic genes
GB8818684D0 (en) * 1988-08-05 1988-09-07 Raychem As Heater mounting arrangement

Also Published As

Publication number Publication date
EP0379395B1 (en) 1994-07-27
JP2787458B2 (ja) 1998-08-20
JPH02190189A (ja) 1990-07-26
US5081023A (en) 1992-01-14
EP0379395A2 (en) 1990-07-25
DE69010924T2 (de) 1994-11-24
DE69010924D1 (de) 1994-09-01
EP0379395A3 (en) 1991-10-02
CA2008147A1 (en) 1990-07-20

Similar Documents

Publication Publication Date Title
ES2057454T3 (es) Antibiotico l53-18a y procedimiento para su preparacion.
AU2003283282A1 (en) Tubulysins, method for producing the same and tubulysin preparations
ES2052574T3 (es) Antibioticos glicopeptidos.
MA23490A1 (fr) Derives de lipopeptide, procede pour leur preparation, composition les contenant et leur utilisation .
FI853914A0 (fi) Antibiotikum a 40926 och dess rena faktorer pa, pb, a, b och b0.
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
DK0748387T3 (da) Fremgangsmåde til isolation af clavulansyre og farmaceutisk acceptable salte deraf fra fermenteringsvæsken af Streptomyces sp. P 6621 FERM P 2804
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DE68918944D1 (de) Künstliche rezeptor-analoge.
EP0552257A4 (en) A plant protein useful for treating tumors and hiv infection
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DK0664811T3 (da) Gestagent aktive 4-estrener med bro mellem stillingerne 19,11
AU3567397A (en) Naphthyridines which affect il-4 and g-csf
DK0465895T3 (da) WS7622A-disulfat, fremgangsmåde til fremstilling deraf og anvendelse deraf
Cross Jr Homologous dura use in problem pocket repair
ATE164764T1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
DK0874863T3 (da) 3-deoxy-3-descladinose-derivater fra erythromycin A og B
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
ES2062062T3 (es) Procedimiento para la preparacion de eteres de la 2-amino-7-hidroxitetralina.
FR2578424B1 (fr) Souches mutantes, vaccinantes de bacteries, leur procede d'obtention, et preparations vaccinales les contenant
ITMO920002A0 (it) -strumenti e loro metodo di utilizzazione per l'insegnamento di tecniche medico chirurgiche e infermieristiche.
RU96113802A (ru) Способ лечения ограниченного острого одонтогенного остеомиелита челюстей
NO974687D0 (no) Kondenserte <beta>-carboliner
TH31976A (th) การทำโพรพิลีน ออกไซด์ให้บริสุทธิ์

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 379395

Country of ref document: ES